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Is Peer Support in Group Clinics as Effective as
Traditional Individual Appointments? The First Study in
Patients With Celiac Disease
Anupam Rej, MBChB, BMedSci, MRCP1, Nick Trott, RD, MSc1, Matthew Kurien, MBChB, MRCP, MD1,2, Federica Branchi, MD1,3,
Emile Richman, BSc, MSc4, Sreedhar Subramanian, MD, MRCP4 and David Surendran Sanders, MBChB, MRCP, MD, FACG, FRCP1,2
INTRODUCTION: Celiac disease (CD) is common, affecting approximately 1% of the population. The cornerstone of
management is a gluten-free diet, with dietetic advice being the key to aiding implementation. The aim
of the study was to assess group clinics in comparison with traditional individual appointments.
METHODS: Patients with a new diagnosis of CD, confirmed histologically, were prospectively recruited over 18
months in Sheffield, United Kingdom. Patients received either a group clinic or traditional one-to-one
appointment, led by a dietitian. Quality-of-life questionnaires were completed at baseline, as well as
biochemical parameters being recorded. Patients were followed up at 3 months, where adherence
scores were assessed as well as biochemical parameters and quality of life questionnaires being
completed.
RESULTS: Sixty patients with CD were prospectively recruited and received either an individual (n5 30) or group
clinic (n 5 30). A statistically significant reduction in tissue transglutaminase was noted following
group clinics (mean 58.5, SD 43.4 U/mL vs mean 13.2, SD 5.7 U/mL, P < 0.01). No significant
differences in baseline and follow-up biochemical parameters between one-to-one and group clinics
were noted. At follow-up, there was no statistically significant difference betweenmean gluten-free diet
adherence scores (mean 3.1, SD 0.4 vs mean 3.1, SD 0.7, P5 0.66) between one-to-one and group
clinics.
DISCUSSION: This first study assessing group clinics inCDdemonstrates they are as effective as traditional one-to-one
clinics, with the addedbenefits of peer support and greater efficiency, with anestimated54%reduction
of dietetic resources.
Clinical and Translational Gastroenterology 2020;11:e00121. https://doi.org/10.14309/ctg.0000000000000121
INTRODUCTION
Celiac disease (CD) is a chronic immune-mediated enteropathy,
which is triggered by gluten ingestion in genetically susceptible
individuals (1). CD is common, with a prevalence of approxi-
mately 1% (2,3). However, many individuals with CD remain
undiagnosed. In the United States, more than 80% of individuals
with CD were undiagnosed in 2009, although this has decreased
to below 50% in 2013–2014 (4). There has been a rise in the
diagnosis of CD over recent decades, with almost a four-fold
increase in the incidence rate in the United Kingdom between
1990 and 2011, from 5.2 per 100,000 to 19.1 per 100,000 person-
years (5).
The cornerstone formanagement of CD remains a gluten-free
diet (GFD) (6), to prevent complications such as an increased risk
of bone fractures and malignancy (7,8). Adherence to a GFD
however can be challenging, with a reduction in patient wellbeing
and psychological distress being noted (9), with reported adher-
ence between 42% and 91% in the literature (10). It is therefore
essential that newly diagnosed individuals are seen by dietitians,
so hidden sources of gluten can be identiﬁed, as well as to ensure
healthy gluten-free substitute grains are provided to ensure ade-
quate ﬁber and nutrient content are met (6). This is also the
preferred method for patients, who want to be seen by a dietitian
with a doctor available (11).
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Currently, celiac dietetic advice is provided by one-to-one
appointments. However, dietetic group clinics have been pro-
posed as a new method to manage these patients (12). Potential
beneﬁts of this approach include the ability for peer support, with
peer support having been shown to improve outcomes in patients
with both diabetes and hypertension (13–15). The eﬀectiveness of
group clinics has also been demonstrated in the ﬁeld of gastro-
enterology, in particular group clinics for the low fermentable
oligosaccharides, disaccharides, monosaccharides, and polyol
diet in patients with irritable bowel syndrome (16). The rise in
diagnosis of CD has also resulted in an increased demand in
healthcare services and led to a strain on existing resources. There
appears to be a wide variation in the provision of dietetic services
for CD in the United Kingdom, with many centres failing to
deliver the required provision as suggested by UK national
guidelines (17). Group clinics may provide an opportunity to
standardize dietetic care in CD, both in the United Kingdom and
globally.
Although there are several potential beneﬁts of group
clinics, little is known on its eﬃcacy for patients with newly
diagnosed CD in comparison with traditional one-to-one
appointments. As a result of this, this study aimed to assess
the outcomes of the novel set up of group clinics in com-
parison with traditional one-to-one clinics for the ﬁrst time
in CD.
METHODS
Study design and patients
Participants were prospectively recruited and allocated over an
18-month period through referrals from primary and secondary
care to the dietetic service at Sheﬃeld Teaching Hospitals, United
Kingdom. Participants were recruited for group clinics initially.
After this, participants were recruited for one-to-one clinics. The
study ceased once 30 participants had been recruited for both
group and one-to-one clinics. Participants were not given a choice
in allocation to intervention.
Patients older than 18 yearswith newly diagnosed celiac disease
were recruited, as deﬁned as a either a positive immunoglobulin A
(IgA)-tissue transglutaminase (TTG) or IgA-endomysial antibody
(EMA) in conjunction with biopsy-proven CD (Marsh 3a or
above). Patients with multiple diagnoses (e.g., Crohn’s disease,
Figure1.Topicscovered inone-to-oneandgroupclinics.BMI,bodymass index;CD, celiacdisease;DEXA,dual energy x-rayabsorptiometry;GFD, gluten-freediet.
Figure 2. Flow chart for participants during trial.
Table 1. Baseline demographics
Demographic
One-to-one clinics
(n 5 30)
Group clinics
(n 5 30)
P
value
Gender 0.70a
Female, n (%) 22 (73.3) 17 (56.7)
Male, n (%) 8 (26.7) 13 (43.3)
Age (yr), mean 6 SD 45.7 6 17.2 50.7 6 14.8 0.24b
Weight (kg), mean 6 SD 70.8 6 14.6 77.9 6 19.4 0.12b
BMI (kg/m2), mean 6 SD 24.4 6 3.9 26.5 6 4.2 0.05b
Time seen from initial
diagnosis (wk), mean 6 SD
10.7 6 11.0 11.3 6 10.3 0.84b
Follow-up duration (wk),
mean 6 SD
16.1 6 14.5 12.6 6 2.2 0.19
BMI, body mass index.
a
x
2 test.
bIndependent t test.
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ulcerative colitis, and diabetesmellitus), communication barriers,
and who had speciﬁcally requested an individual clinic were
excluded.
The median group size was 6 participants (minimum 4,
maximum 9; total 5 groups). The same topics were covered in
group clinics vs one-to-one appointments and included educa-
tion on a GFD, prescriptions, traveling, and information on
Coeliac UK (Figure 1). Both sessions relied on discussion with the
dietitians with PowerPoint presentations.
All patients had nutritional assessments at baseline (ﬁrst
appointment) and bloods performed in line with British So-
ciety of Gastroenterology guidelines. Baseline demographics,
celiac serology (IgA-EMA and IgA-TTG), hemoglobin, ad-
justed calcium, vitamin D, vitamin B12, folate, and ferritin
levels were recorded. Validated questionnaires were com-
pleted at baseline, which were the Short-Form 36 (SF-36)
survey (18) and Hospital Anxiety and Depression Score
(HADS) (19).
Table 2. Comparison of biochemical markers, adherence scores and questionnaire data between one-to-one clinics and group clinics at
baseline and follow-up
Baseline Follow-up Baseline vs follow-up
One-to-one
clinics (n 5 30)
Group clinics
(n5 30)
P
value
One-to-one
clinics (n 5 30)
Group clinics
(n5 30)
P
value
One-to-one clinics
(n5 30), P value
Group clinics
(n5 30), P value
Biochemical markers
EMA
Positive, n (%) 30 (100.0) 27 (90.0) N/Aa 12 (40.0) 8 (28.6)b 0.67c
Negative, n (%) 0 (0.0) 3 (0.0) 18 (60.0) 20 (71.4)b
TTG (U/mL),
mean 6 SD
71.0 6 43.5 63.4 6 45.2 0.51d 22.1 6 36.9 13.2 6 15.7e 0.25d ,0.01a ,0.01a
Hemoglobin (g/dL),
mean 6 SD
135.4 6 13.1 142.1 6 13.7 0.06d 134.1 6 23.7 133.2 6
35.2b
0.92d 0.73a 0.45a
Ferritin (mg/L),
mean 6 SD
64.1 6 65.3 99.4 6 140.3 0.22d 70.1 6 82.1 126.8 6
172.5f
0.11d 0.44a 0.21a
B12 (ng/L),
mean 6 SD
363.7 6 163.3 326.3 6
122.5
0.32d 452.6 6 339.1 392.8 6
186.6f
0.41d 0.19a 0.08a
Folate (mg/L),
mean 6 SD
9.9 6 6.6 8.2 6 3.9 0.21d 11.2 6 4.9 11.6 6 4.8f 0.72d 0.31a ,0.01a
Vitamin D (nmol/L),
mean 6 SD
62.9 6 30.3f 52.6 6 27.9e 0.20d 74.4 6 23.2 75.3 6 28.9f 0.90d ,0.01a ,0.01a
Adjusted calcium
(mmol/L), mean 6 SD
2.3 6 0.1 2.3 6 0.1f 0.53d 2.4 6 0.1f 2.3 6 0.1e 0.38d 0.03 0.26a
Adherence questionnaire
Biagi adherence score,
mean 6 SD
3.1 6 0.4 3.1 6 0.7 0.66d
Questionnaire data
SF-36 physical
summary, mean6 SDg
45.8 6 9.6 47.3 6 9.3 0.54d 47.3 6 8.9 45.8 6 9.2 0.52d 0.19a 0.35a
SF-36 mental
summary, mean6 SDg
46.5 6 9.8 44.6 6 10.9 0.47d 46.4 6 9.5 44.8 6 11.8 0.57d 0.91a 0.84a
HADS anxiety,
mean 6 SDh
6.1 6 4.0 7.6 6 4.8 0.18d 5.3 6 3.1 7.6 6 4.9 0.04d 0.17a 0.94a
HADS depression,
mean 6 SDh
4.2 6 3.4 4.8 6 3.8 0.52d 3.8 6 3.4 4.8 6 4.1 0.32d 0.47a 1.00a
EMA, endomysial antibody; HADS, Hospital Anxiety and Depression; SF-36, Short-Form 36; TTG, tissue transglutaminase.
aPaired t-test.
bMissing values n 5 28.
c
x
2 test.
dIndependent-samples t test.
eMissing values n 5 27.
fMissing values n 5 29.
gSF-36 is based on norm-based scoring i.e., average population is noted to have a score of 50 with an SD of 10, with a lower score indicating poorer health.
hAn HADS score of more than 11 implies a definite cause of anxiety or depression, a cutoff of 8–10 a probable case and 7 or less not being the case.
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After this, all patients were re-evaluated at a 3-month follow-
up appointment. At this point, adherence was assessed using
a validated questionnaire (Biagi score), as well as celiac serology
(IgA-EMA, IgA-TTG), hemoglobin, adjusted calcium, vitaminD,
vitamin B12, folate, and ferritin levels being recorded. SF-36
survey and HADS were once again completed. Figure 2 outlines
the study ﬂow.
Celiac serology
Enzyme-linked immunosorbent assay kits (Aesku Diagnostics,
Wendelsheim, Germany) were used to assay TTG antibodies. A
TTG titer of .7 U/mL was regarded as positive as per manu-
facturer’s guidance. IgA-EMA was detected by immunoﬂuo-
rescence on oesophageal sections (Binding Site, Birmingham,
United Kingdom). Total IgA was measured using Behring
BN2 nephelometer (Haywards Heath, West Sussex, United
Kingdom).
Dietary adherence questionnaire
A validated questionnaire was used devised by Biagi et al. (20),
which ismade of 5 levels (0–4). Scores of 0 or 1were deﬁned as not
following a strict GFD; score of 2 was deﬁned as following a GFD
but with important errors that require correction. Patients with
a score of 3 or 4 were deﬁned as following a strict GFD.
Ethical considerations
The study protocol was approved by the Yorkshire and Humber
Research Ethics committee and registered with the local research
and development department of Sheﬃeld Teaching Hospital
NHS Foundation Trust (REC reference 14/YH/1216). Written
consent was obtained from all patients.
Statistical analysis
All data were analyzed using SPSS version 24 (International
Business Machines, Armonk, NY). Data were summarized using
descriptive statistics, including counts and percentages for cate-
gorical data and mean 6 SD for continuous data. Paired t tests
were used to compare continuous data within groups, with the
independent t test to compare continuous data between groups.
Comparison between categorical data between both groups was
performed using x2 testing. Statistical signiﬁcance was considered
when P , 0.05.
RESULTS
A total of 87 patients with newly diagnosed CD were pro-
spectively recruited and allocated for a dietetic consultation be-
tween December 2014 and August 2016. Of these, 16 patients
(18.4%) failed to attend their ﬁrst appointment, with 11 patients
(12.6%) failing to attend their follow-up appointment. Of the
remaining 60 patients (n 5 39 female, mean age 48.2 6 16.1
years), 30 patients were seen in group clinics and 30 had one-to-
one appointments (Figure 2).
The demographics of all patients are outlined inTable 1. There
was no diﬀerence in baseline age (P 5 0.24), weight (P 5 0.12),
bodymass index (P5 0.05), time seen from initial diagnosis (P5
0.84), or follow-up duration (P 5 0.19) between group clinic
patients and one-to-one appointment patients.
Table 2 shows the outcomes of patients after being seen in the
both one-to-one and group clinics. The mean duration of follow-
up in group clinics was 12.66 2.2 weeks. A statistically signiﬁcant
reduction in TTG was noted after group clinics (63.4 6 43.4
U/mL vs 13.2 6 15.7 U/mL, P , 0.01), as well as an increase in
folate levels (8.2 6 3.9 mg/L vs 11.6 6 4.8 mg/L, P , 0.01) and
vitamin D levels (52.66 27.9 nmol/L vs 75.36 28.9 nmol/L, P,
0.01). No diﬀerences in hemoglobin, ferritin, B12, adjusted cal-
cium, SF-36, and HADS were noted after being seen in a group
clinic.
Themean duration of follow-up in one-to-one clinics was 16.1
6 14.5 weeks. A statistically signiﬁcant reduction in TTG was
noted after one-to-one clinics (71.06 43.5 U/mL vs 22.16 36.9
U/mL,P, 0.01), as well as an increase in vitaminD levels (62.96
30.3 nmol/L vs 74.4 6 23.2 nmol/L, P , 0.01) and adjusted
calcium levels (2.36 0.1mmol/L vs 2.46 0.1mmol/L, P, 0.01).
No diﬀerences in hemoglobin, ferritin, B12, folate, SF-36, and
HADS were noted after being seen in a group clinic.
There was no signiﬁcant diﬀerence in baseline and follow-up
biochemical parameters, between one-to-one and group clinics,
as seen in Table 2. At follow-up, there was no statistically sig-
niﬁcant diﬀerence between mean GFD adherence scores (3.1 6
0.4 vs 3.16 0.7, P5 0.66) between one-to-one and group clinics.
The HADS Anxiety score was higher in the group clinics vs one-
to-one clinics at follow-up (7.66 4.9 vs 5.36 3.1, P5 0.04). No
other diﬀerences in baseline and follow-up SF-36 and HADS
scores were noted between one-to-one and group clinics.
The potential time savings of a group clinic were calculated, as
seen in Table 3. Time savings were based on the length of the
group clinic being estimated at 90minutes, in comparisonwith 60
minutes for a one-to-one appointment, with an average of 6
patients per group clinic. As can be seen from Table 3, the esti-
mated time savings for group clinics was 28 hours (54%
reduction).
DISCUSSION
Our ﬁndings support that dietetic led intervention is eﬀective for
the management of newly diagnosed CD. This is the ﬁrst study to
demonstrate that group clinics are as eﬀective as one-to-one
clinics in the delivery of CD dietetic advice in patients with newly
diagnosed CD. Both dietetic interventions led to similar adher-
ence at follow-up, with improvement in noninvasive serological
markers, with no diﬀerence between groups. Although serological
markers and questionnaires were used to assess adherence in
addition to the dietary review, it is known that serology may not
accurately predict mucosal recovery (21), as well as patients being
seen at relatively short-term follow-up. Nonetheless, the Biagi
score is a validated score to assess adherence in CD (20), with
Table 3. Time comparison of group vs one-to-one clinics
(n 5 30 per group)
Actual time spent for
group clinics
Estimated equivalent time for
one-to-one clinic
Patient education
(hr)
7.5 30.0
Resource
development (hr)
14.0 14.0
Postclinic
documentation
(hr)
2.0 7.5
Total hours 23.5 51.5
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a mean score of greater than 3 being seen in both group and one-
to-one clinics in this study, suggesting strict adherence for
patients in both groups. This highlights that group clinics are
likely to result in strict GFD adherence for patients with CD.
Nutritional adequacy can be a concern on the implementation
of a GFD (22), with this study noting no diﬀerence between
groups with regards to B12, folate, ferritin, and adjusted calcium.
Quality-related measures of life were also not diﬀerent between
groups, other than noting that individuals having one-to-one
clinics had a statistically signiﬁcantly lower HADS anxiety scores
than group therapy at follow-up. However, this is unlikely to be of
clinical signiﬁcance as themeanHADS scores in both one-to-one
and group clinics were below 8, which is the threshold for
probable anxiety or depression (19). It is also important to note
that therewere no changes seen in other quality of life parameters.
There were signiﬁcant improvements in folate and vitamin D
levels after patients received group therapy, as well as reductions
in TTG levels. This highlights that group therapymay beneﬁcially
improve these parameters. Itmust be noted that these ﬁndings for
group clinics were seen at amean follow-up 12.66 2.2 weeks. It is
therefore unclear whether these parameters would bemaintained
at a longer follow-up period, with further research required to
assess long term biochemical parameters in individuals with CD
receiving advice via group clinics.
Theoverallﬁndings of this studyare in linewith similarmethods
used for other dietetic clinics, such as the low fermentable oligo-
saccharides, disaccharides,monosaccharides, andpolyols approach,
where group clinics have been shown tobe as eﬀective as one-to-one
advice (16). This has also been seen in type 2 diabetes, which has
demonstrated group based self-management education to be as
eﬀective as routine management (15). In addition to group clinics
showing equally eﬃcacy to traditional individual appointments,
there is also likely to be the added beneﬁt of peer-to-peer support
provided by group clinics, which is not available in individual
appointments. Also, face-to-face social networks have been shown
to be associated with higher quality-of-life scores in patients with
CD, which group clinics provide (23). It also appears that group
clinics are a cost-eﬀective intervention, with a 54% reduction in the
number of dietetic hours required to deliver this service.
The strength of this study includes it methodology. Patients
with a diagnosis of conﬁrmed CD through serological and his-
tological markers were only included, with patients with multiple
diagnoses excluded. This ensured that the changes seen after di-
etetic advice were a result of CDmanagement, rather than a result
of other coexistent pathology, such as diabetes mellitus. Also, the
dietary advice given to patients was uniform, preventing bias.
A potential limitation of the study was that this study was
performed in a tertiary center. As this studywas performed in one
specialized unit in the United Kingdom, it may not be applicable
to other centers, which may diﬀer in dietary expertise. However,
the information given in clinics was standardized, with the aim of
generalizability of care for these patients and to reduce geo-
graphical variation, which is currently occurring, as seen from the
survey from Coeliac UK on the provision of dietetic services (17).
However, further studies assessing group therapies in CD in the
United Kingdom and globally, with collaboration between dif-
ferent centres, may help standardization of care further. Also,
patient and public involvement may help facilitate this.
This ﬁrst study assessing group clinics in newly diagnosed CD
demonstrates that this is a cost-saving intervention, with an es-
timated 54% reduction in dietetic resources, with no detriment to
patient education andGFD adherence. Group clinics also provide
the added beneﬁts of peer support, and are likely to be beneﬁcial
globally, with further studies required to assess this.
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Study Highlights
WHAT IS KNOWN
3 Internationally, dietetic advice (GFD) for patients with CD is
delivered by dietitians on a one-to-one basis.
3 Group clinics have been demonstrated to be effective in other
medical conditions but have yet to be assessed in CD.
WHAT IS NEW HERE
3 Group clinics have been shown to be as effective as individual
appointments in CD.
3 Peer support is an added benefit of group clinics.
3 Group clinics are more efficient than one-to-one
appointments, with a 54% reduction in dietetic resources.
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